Nearly 50% of bladder cancer patients either present with metastatic disease or relapse
distantly following initial local therapy. Prior to platinum-based chemotherapy, the incidence …

Bladder cancer (BCa) is a leading cause of cancer worldwide with high incidence and
mortality across all ages. Early diagnosis and treatment can lead to significantly improved …

Naturally occurring canine invasive urinary carcinoma (iUC) closely resembles human
muscle invasive bladder cancer in terms of histopathology, metastases, response to therapy …

Squamous cell carcinomas are therapeutically challenging tumor entities. Low response
rates to radiotherapy and chemotherapy are commonly observed in squamous patients and …

Purpose: Cisplatin-based neoadjuvant chemotherapy (NAC) is the standard of care in non-
metastatic muscle-invasive bladder cancer (MIBC). There are limited data regarding the …

Background Lactate is an important carbon source for cell metabolism as well as a signaling
molecule in normal, chronic inflammatory and cancer tissues. However, the relationship …

Many species are vulnerable or on the verge of extinction as a result of increased habitat
degradation and fragmentation. Conservation genetics has attempted to apply an …

Background and Aim: Radical cystectomy is the treatment of choice for muscle-invasive
bladder cancer. Although open surgery is currently the gold standard for this procedure, it …

Urothelial bladder cancer (BC) is the ninth most common cancer worldwide, with a higher
incidence in highincome countries [1, 2] and ranks thirteenth in terms of mortality rate [3] …

Aim: The purpose of this study is to evaluate the diagnostic usefulness of combining
cystoscopy and urine cytology in the diagnosis of urothelial neoplasia. Material and …